Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease
- 1 January 2007
- journal article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 156 (1), 91-98
- https://doi.org/10.1530/eje.1.02323
Abstract
Objective: Though transsphenoidal surgery remains the first-line treatment of Cushing’s disease, recurrence occurs frequently. Conventional radiotherapy and anticortisolic drugs both have adverse effects. Stereotactic radiosurgery needs to be evaluated more precisely. The aim of this study was to determine long-term hormonal effects and tolerance of gamma knife (GK) radiosurgery in Cushing’s disease. Design: Forty patients with Cushing’s disease treated by GK were prospectively studied over a decade, with a mean follow-up of 54.7 months. Eleven of them were treated with GK as a primary treatment. Methods: Radiosurgery was performed at the Department of Functional Neurosurgery of Marseille, France, using the Leksell Gamma Unit B and C models. Median margin dose was 29.5 Gy. Patients were considered in remission if they had normalized 24-h free urinary cortisol and suppression of plasma cortisol after low-dose dexamethasone suppression test. Results: Seventeen patients (42.5%) were in remission after a mean of 22 months (range 12–48 months). The two groups did not differ in terms of initial hormonal levels. Target volume was significantly higher in uncured than in remission group (909.8 vs 443 mm3, P = 0.038). We found a significant difference between patients who were on or off anticortisolic drugs at the time of GK (20 vs 48% patients in remission respectively, P = 0.02). Conclusion: With 42% of patients in remission after a median follow-up of 54 months, GK stereotactic radiosurgery, especially as an adjunctive treatment to surgery, may represent an alternative to other therapeutic options in view of their adverse effects. Abstract Objective: Though transsphenoidal surgery remains the first-line treatment of Cushing’s disease, recurrence occurs frequently. Conventional radiotherapy and anticortisolic drugs both have adverse effects. Stereotactic radiosurgery needs to be evaluated more precisely. The aim of this study was to determine long-term hormonal effects and tolerance of gamma knife (GK) radiosurgery in Cushing’s disease. Design: Forty patients with Cushing’s disease treated by GK were prospectively studied over a decade, with a mean follow-up of 54.7 months. Eleven of them were treated with GK as a primary treatment. Methods: Radiosurgery was performed at the Department of Functional Neurosurgery of Marseille, France, using the Leksell Gamma Unit B and C models. Median margin dose was 29.5 Gy. Patients were considered in remission if they had normalized 24-h free urinary cortisol and suppression of plasma cortisol after low-dose dexamethasone suppression test. Results: Seventeen patients (42.5%) were in remission after a mean of 22 months (range 12–48 months). The two groups did not differ in terms of initial hormonal levels. Target volume was significantly higher in uncured than in remission group (909.8 vs 443 mm3, P = 0.038). We found a significant difference between patients who were on or off anticortisolic drugs at the time of GK (20 vs 48% patients in remission respectively, P = 0.02). Conclusion: With 42% of patients in remission after a median follow-up of 54 months, GK stereotactic radiosurgery, especially as an adjunctive treatment to surgery, may represent an alternative to other therapeutic options in view of their adverse effects.Keywords
This publication has 27 references indexed in Scilit:
- Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term ResultsJournal of Clinical Endocrinology & Metabolism, 2004
- The Nelson's syndrome... revisitedPituitary, 2004
- Radiosurgery for pituitary adenomasClinical Endocrinology, 2004
- Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experienceClinical Endocrinology, 2000
- The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's DiseaseNew England Journal of Medicine, 1997
- Role of radiation therapy in clinical hormonally-active pituitary adenomasRadiotherapy and Oncology, 1996
- Radiation Therapy of Pituitary TumorsAmerican Journal of Clinical Oncology, 1991
- RADIATION‐INDUCED HYPOPITUITARISM IS DOSE‐DEPENDENTClinical Endocrinology, 1989
- Treatment of Cushing's disease with low dose radiation therapy.BMJ, 1984
- The natural history of cushing's syndromeAmerican Journal Of Medicine, 1952